Joint Symposium by the Pharmaceutical Manufacturers Association of Japan (PMAJ) Aging Group and the Health Policy Institute of Japan (HGPI) Report on "Health Challenges Associated with Aging, Dementia and Cancer: Early Approaches to Extending Healthy Life Expectancy Theme: Toward disease preparedness, early detection, consultation with specialists, and a society where people can live together
On September 8, 2023, a joint symposium was held at the Nihonbashi Life Science Hub (Chuo-ku, Tokyo) by the Pharmaceutical Cooperative Aging Group and the Health Policy Institute of Japan (HGPI). This event also served as a follow-up to the " Pharmaceutical Industry Recommendations for the G7 Hiroshima Summit Health Agenda " jointly issued by the Pharmaceutical Manufacturers Association of Japan (PMAJ) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in November 2022 in preparation for the G7 Hiroshima Summit and Nagasaki Health Ministers Meeting. The event focused on dementia and cancer, both of which are common among the elderly. Approximately 150 people from the media and the general public attended the event. We hope that the keynote speeches, panel discussion, and this report will help to raise awareness and encourage preparedness for extending healthy life expectancy in Japan.
Event Report
Program
Speakers' titles are omitted.
| Opening | Shoko Nakagawa, Executive Director, Japan Pharmaceutical Manufacturers Association |
| Keynote Speech 1
Toward the realization of disease-modifying therapies for Alzheimer's disease | Takeshi Iwatsubo, Professor, Department of Neuropathology, Graduate School of Medicine, The University of Tokyo,
Director, National Institute of Neurological Research, National Center of Neurology and Psychiatry |
| Keynote Speech 2
Challenges in Health Care and Cancer in an Aging Population | Hitoshi Nakagama, President, National Cancer Center |
| Panel Discussion
Thinking about the "preparedness" of society as a whole against dementia and cancer | Panelists
Takeshi Iwatsubo, Professor, Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Director, National Institute of Neurological Research, National Center of Neurology and Psychiatry Hitoshi Nakagama President, National Cancer Center Matsuyo Kamata, President, Association of People with Dementia and their Families, Public Interest Incorporated Association Rin Ogiya, Director, Cancer Control Promotion, Cancer and Disease Control Division, Health and Welfare Bureau, Ministry of Health, Labour and Welfare Moderator Shunichiro Kurita, Senior Manager, HGPI, Health Policy Institute of Japan |